Leventoğlu Emre, Uzun Kenan Bahriye, Büyükkaragöz Bahar, Bakkaloğlu Sevcan A
Pediatric Nephrology, Faculty of Medicine, Gazi University, Ankara, TUR.
Cureus. 2023 Mar 19;15(3):e36379. doi: 10.7759/cureus.36379. eCollection 2023 Mar.
Acute tubulointerstitial nephritis (ATIN) is an infiltration of the kidney interstitium with inflammatory cells. Medications are most frequently blamed for the etiology. Patients may present with non-specific signs and symptoms. Therefore, the diagnosis of ATIN is often delayed. In this study, clinical characteristics, treatment protocols, and outcomes of children diagnosed with ATIN were presented.
This is a retrospective study based on the data of 18 patients diagnosed with ATIN between 2017 and 2022 at Gazi University. Patients were divided into two groups: steroid-treated (n=13) and non-steroid-treated (n=5). Clinical features and laboratory evaluations were compared between the groups.
The mean age of the patients was 14.4±2.6 years, and the great majority were girls (88.9%, n=16). ATIN was mostly medication-related (n=17, 94.4%). Steroids were started in one-third of patients using non-steroidal anti-inflammatory drugs. Steroids were started in 45.4% of the patients with eosinophilia, 75% of those with pyuria, 66.6% of those with hematuria, and half of the patients with increased kidney echogenicity. The kidney functions returned to normal ranges in all patients. In steroid-treated patients, although recovery times for serum creatinine were longer (7.2±2.5 vs. 71.2±100.7 days), blood eosinophil count reached normal values more rapidly (5.4±2.3 vs. 3.1±1.0 days).
ATIN can be associated with diverse clinical presentations. The first and most important step of treatment is to discontinue the medication responsible for the etiology. Steroid treatment improves eosinophilia more rapidly. However, randomized controlled studies are needed to determine further treatment steps and establish a more definite treatment protocol.
急性肾小管间质性肾炎(ATIN)是肾间质出现炎性细胞浸润。病因大多归咎于药物。患者可能表现出非特异性体征和症状。因此,ATIN的诊断常常延迟。本研究呈现了诊断为ATIN的儿童的临床特征、治疗方案及预后。
这是一项基于2017年至2022年在加齐大学诊断为ATIN的18例患者数据的回顾性研究。患者分为两组:接受类固醇治疗组(n = 13)和未接受类固醇治疗组(n = 5)。比较两组的临床特征和实验室评估结果。
患者的平均年龄为14.4±2.6岁,绝大多数为女孩(88.9%,n = 16)。ATIN大多与药物相关(n = 17,94.4%)。三分之一使用非甾体抗炎药的患者开始使用类固醇。嗜酸性粒细胞增多患者中有45.4%开始使用类固醇,脓尿患者中有75%,血尿患者中有66.6%,肾回声增强患者中有一半开始使用类固醇。所有患者的肾功能均恢复到正常范围。在接受类固醇治疗的患者中,虽然血清肌酐恢复时间较长(7.2±2.5天对71.2±100.7天),但血液嗜酸性粒细胞计数达到正常值更快(5.4±2.3天对3.1±1.0天)。
ATIN可伴有多种临床表现。治疗的首要也是最重要的步骤是停用致病药物。类固醇治疗能更快改善嗜酸性粒细胞增多情况。然而,需要进行随机对照研究以确定进一步的治疗步骤并建立更明确的治疗方案。